
Purpose: To compare the outcomes of 3 different surgical techniques for orbital implantation: 2-petal evisceration, 4-petal evisceration, and enucleation with “on-the-table” evisceration. Methods: We retrospectively reviewed the clinical charts of all patients who underwent evisceration surgery with orbital implantation at our center between 2015 and 2023. Patients were categorized into 3 groups based on the surgical technique used: 4-petal evisceration, 2-petal evisceration, and enucleation with “on-the-table” evisceration, which involved enucleation followed by an evisceration with autologous sclera wrapping on the anterior surface of the implant. Results: 231 patients were included. The mean duration of surgery was 60.4 minutes and was statistically significantly lower in the 2-petal group (47.6 minutes). There was no statistical difference between the groups in terms of complications, as only 8 patients experienced implant exposure (3.5%) and 2 patients developed chronic infection that necessitated implant removal (0.9%). Both mobility and aesthetic results were considered satisfactory for the majority of patients. One-third of patients underwent a secondary procedure, with ptosis surgery being the most common (19.9%), followed by lipostructure (fat grafting) (10.4%). The only significant statistical difference observed among the groups was implant size, which was notably larger in the “on-the-table” group. Conclusion: The 3 different surgical techniques are similar in terms of complications and functional outcomes.
PURPOSE Blepharoplasty is one of the most commonly performed cosmetic surgical procedures worldwide. Carbon dioxide (CO2) laser-assisted blepharoplasty has been proposed as an alternative to conventional cold-steel techniques, with potential advantages in hemostasis and postoperative recovery. However, the comparative evidence remains limited and has not been systematically synthesized. This study aimed to evaluate the comparative efficacy and safety of CO2 laser versus conventional scalpel blepharoplasty. METHODS A systematic review and meta-analysis were conducted in accordance with the Cochrane Handbook and Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. PubMed, Embase, Scopus, and the Cochrane Central Register of Controlled Trials were searched from inception to November 2025. Comparative studies comparing CO2 laser blepharoplasty with conventional scalpel blepharoplasty were included. For binary paired outcomes, odds ratios (OR) were computed from discordant-pair counts in split-face studies using a McNemar-type approach with Haldane-Anscombe correction. A DerSimonian-Laird random-effects model was used for all pooled analyses. RESULTS Four comparative studies involving 133 patients were included. Three employed a split-face design in which the CO2 laser was used on one eyelid and the conventional scalpel with electrocautery on the contralateral eyelid, and one used a nonpaired comparison. For postoperative ecchymosis, the pooled OR from 3 split-face studies was 8.05 (95% confidence interval: 1.73-37.35; p = 0.008; I2 = 0%), indicating significantly worse bruising on the scalpel-treated side. For postoperative edema, the pooled OR was 7.40 (95% confidence interval: 1.21-45.10; p = 0.030; I2 = 0%), which also favored the laser. All 4 studies consistently reported reduced intraoperative bleeding with the CO2 laser, describing a nearly bloodless operative field on the laser side compared with minimal-to-substantial bleeding on the scalpel side. Three studies assessed postoperative pain and discomfort; 2 found no difference between sides, whereas 1 reported no discomfort on the laser side but discomfort on the scalpel side. Quantitative data for bleeding and pain were unavailable, precluding formal meta-analysis of these outcomes. CONCLUSION Carbon dioxide laser blepharoplasty significantly reduces postoperative ecchymosis and edema and improves intraoperative hemostasis compared with conventional techniques, with similar long-term outcomes.
Eyelid margin myxomas are rare benign tumors that may presage Carney complex before potentially lethal cardiac manifestations develop. We report a 59-year-old woman with an enlarging left lower eyelid margin lesion, clinically suspicious for malignancy. Excisional biopsy with histopathological and immunohistochemical evaluation confirmed myxoma. Personal and family histories revealed no features suggestive of Carney complex, and no local recurrence was observed at 3-month follow-up. This case highlights the diagnostic challenge of eyelid margin myxomas and the oculoplastic surgeon’s opportunity to recognize a cutaneous clue to clinically significant systemic disease.
Purpose: While oral nicotinamide use has been shown to decrease subsequent nonmelanoma skin cancer, the role of nicotinamide in eyelid cancer prevention has not been previously examined. Methods: This retrospective cohort study used a deidentified database of 150 million patients (January 2006–2026). Among 1,519,126 patients with prior nonmelanoma skin cancer, 12,944 had subsequent oral nicotinamide use within 5 years of diagnosis; after 1:1 propensity score matching, 23,004 patients were analyzed. The primary outcome was incident nonmelanoma eyelid cancer; secondary outcomes included nonmelanoma skin cancer at any body site and eyelid cancer among patients without prior eyelid involvement. Results: The nicotinamide group had significantly fewer eyelid cancers than the no-nicotinamide group (212 [1.84%] vs. 338 [2.94%]; relative risk (RR), 0.627; 95% confidence interval [CI]: 0.529–0.743; p < 0.001), representing a 37.3% RR reduction. This exceeded the risk reduction for nonmelanoma skin cancer anywhere else on the body (RR = 0.771; 95% CI: 0.750–0.792). The reduction in eyelid cancer was concentrated within the first year after nicotinamide initiation (first-year RR = 0.449; 95% CI: 0.358–0.561); no significant difference was observed beyond the first year (RR = 1.023; 95% CI: 0.806–1.298). Conclusions: Oral nicotinamide use was associated with reduced subsequent basal and squamous cell carcinoma in patients with prior skin cancer. The association was most significant in the first year after initiation, suggesting that benefit may be greatest with early and sustained use. Prospective studies are indicated to establish causality and optimal dosing for eyelid cancer chemoprevention.
The transorbital neuro-endoscopic surgical (TONES) approach to resection of tumors involving the superior orbit and skull base describes a minimally invasive technique that avoids larger craniofacial exposure. Described advantages include reduced brain retraction when compared to more extensive cranial approaches, decreased operative time, faster postoperative recovery, and improved cosmetic outcomes. Reported adverse outcomes of this approach include supraorbital nerve injury, eyebrow alopecia, visible scarring, and postoperative soft tissue infection. We describe the case of a patient who underwent infrabrow orbitotomy for a clinoid meningioma and developed orbital osteomyelitis postoperatively. To the best of our knowledge, osteomyelitis of the frontal bone following infrabrow transorbital craniotomy has not been previously reported.